Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor
View Patent ↗A process for production of cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV is provided which employs a BOC-protected amine of the structure prepared by subjecting an acid of the structure to reduce amination by treating the acid with ammonium formate, nicotinamide adenine dinucleotide, dithiothreitol and partially purified phenylalanine dehydrogenase/formate dehydrogenase enzyme concentrate (PDH/FDH) and without isolating treating the resulting amine of the structure 2 with di-tert-butyl dicarbonate to form the BOC-protected amine.
1. A process for preparing the compound of Formula 2
which comprises treating an aqueous solution of the compound of Formula 1
with ammonium formate, nicotinamide adenine dinucleotide, dithiothreitol and partially purified phenylalanine dehydrogenase (PDH) and/or formate dehydrogenase (FDH) enzyme concentrate to provide the compound of Formula 2.
2. The process as defined in claim 1 wherein the partially purified phenylalanine dehydrogenase and/or formate dehydrogenase enzyme concentrate is prepared by a method comprising:
(a) preparing a fermentation broth containing a microorganism capable of producing PDH and/or FDH;
(b) microfluidizing the fermentation broth while maintaining the temperature of said fermentation broth between about 4° C. and 30° C. to form a microfluidized broth containing the PDH and/or FDH;
(c) clarifying the microfluidized broth by treating the broth with aflocculating agent to coagulate cell debris and remove DNA and unwanted proteins, thereby forming a clarified broth;
(d) filtering the clarified broth to give a filtrate; and
(e) concentrating the filtrate to give said partially purified enzyme concentrate, the concentrate containing:
(i) said PDH having a PDH activity of about 400 IU/mL to about 1000 IU/mL; and/or
(ii) said FDH having a FDH activity of about 20 IU/mL to about 200 IU/mL.
3. The process as defined in claim 1 wherein the aqueous solution is warmed to about 35° C. to about 40° C.
4. The process as defined in claim 3 wherein the treating further comprises maintaining the aqueous solution at a pH of about 7.0 to about 8.6.
5. The process as defined in claim 4 wherein the pH is maintained with NaOH.
6. The process as defined in claim 5 wherein the treating comprises reacting the aqueous solution for a period of time from about 24 hours to about 48 hours.
7. A process for preparing the compound of Formula 3
which comprises
(a) treating an aqueous solution of the compound of Formula 1
with ammonium formate, nicotinamide adenine dinucleotide, dithiothreitol and partially purified phenylalanine dehydrogenase and/or formate dehydrogenase enzyme concentrate; and
(b) treating the aqueous solution of step (a) with di-tert-butyl dicarbonate to provide the compound of Formula 3.
8. The process as defined in claim 7 wherein the treating in step (b) further comprises maintaining the aqueous solution at a pH of about 8.5 to about 12.5.
9. The process as defined in claim 7 further comprising isolating the compound of Formula 3.
10. The process as defined in claim 9 further comprising crystallizing the isolated compound of Formula 3.
11. The process as defined in claim 7 wherein the partially purified phenylalanine dehydrogenase and/or formate dehydrogenase enzyme concentrate is prepared comprising:
(a) preparing a fermentation broth containing a microorganism capable of producing PDH and/or FDH;
(b) microfluidizing the fermentation broth while maintaining the temperature of said fermentation broth between about 4° C. and 30° C. to form a microfluidized broth containing the PDH and/or FDH;
(c) clarifying the microfluidized broth by treating the broth with a flocculating agent to coagulate cell debris and remove DNA and unwanted proteins, thereby forming a clarified broth;
(d) filtering the clarified broth to give a filtrate; and
(e) concentrating the filtrate to give said partially purified enzyme concentrate, the concentrate containing:
(i) said PDH having a PDH activity of about 400 IU/mL to about 1000 IU/mL; and/or
(ii) said FDH having a FDH activity of about 20 IU/mL to about 200 IU/mL.
12. The process as defined in claim 2 wherein the enzyme concentrate is capable of reductively aminating a keto-containing compound into a chiral amine-containing compound; wherein said chiral amine-containing compound, without isolation from the enzyme concentrate, is capable of being BOC-protected; and wherein, optionally, the clarifying comprises contacting the microfluidized broth with diatomaceous earth and the filtering comprises filtering the diatomaceous earth with a filter press.
13. The process as defined in claim 2 wherein in step (b) the microfluidizing comprises providing a pressure from about 12,000 to about 20,000 psi.
14. The process as defined in claim 2 wherein in step (b) the temperature of the fermentation broth is maintained between about 4° C. and 25° C.
15. The process as defined in claim 2 wherein in step (b) the temperature of the fermentation broth is maintained between 8° C. and 25° C.
16. The process as defined in claim 2 wherein the PDH is obtained from a microorganism selected from the group consisting of the genera Sporosarcina or Thermoactinomyces.
17. The process as defined in claim 2 wherein the PDH is obtained from Thermoactinomyces intermedius.
18. The process as defined in claim 2 wherein the PDH is a Thermoactinomyces intermedius ATCC 33205 PDH expressed in Escherichia coli and the FDH is a Pichia pastoris ATCC 20864 FDH expressed in Escherichia coli.
19. The process as defined in claim 2 wherein the microorganism is Escherichia coli JM110.
20. The process as defined in claim 2 wherein in step (d) the filtering comprises ultrafiltering the clarified broth through an ultrafiltration membrane or cassette.